vs
Side-by-side financial comparison of Hyatt Hotels Corp (H) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.4B vs $1.8B, roughly 1.3× Hyatt Hotels Corp). Zoetis runs the higher net margin — 25.3% vs -1.1%, a 26.4% gap on every dollar of revenue. On growth, Hyatt Hotels Corp posted the faster year-over-year revenue change (11.7% vs 3.0%). Zoetis produced more free cash flow last quarter ($732.0M vs $236.0M). Over the past eight quarters, Zoetis's revenue compounded faster (4.4% CAGR vs 2.2%).
Hyatt Hotels Corporation, commonly known as Hyatt Hotels & Resorts, is an American multinational hospitality company headquartered in the Riverside Plaza area of Chicago that manages and franchises luxury and business hotels, resorts, and vacation properties. Hyatt Hotels & Resorts is one of the businesses managed by the Pritzker family. Hyatt has more than 1350 hotels and all-inclusive properties in 69 countries, across North America, South America, Europe, Asia, Africa and Australia.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
H vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.4B |
| Net Profit | $-20.0M | $603.0M |
| Gross Margin | — | 70.2% |
| Operating Margin | 0.4% | 31.9% |
| Net Margin | -1.1% | 25.3% |
| Revenue YoY | 11.7% | 3.0% |
| Net Profit YoY | 64.3% | 3.8% |
| EPS (diluted) | $-0.20 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8B | $2.4B | ||
| Q3 25 | $1.8B | $2.4B | ||
| Q2 25 | $1.8B | $2.5B | ||
| Q1 25 | $1.7B | $2.2B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.6B | $2.4B | ||
| Q2 24 | $1.7B | $2.4B | ||
| Q1 24 | $1.7B | $2.2B |
| Q4 25 | $-20.0M | $603.0M | ||
| Q3 25 | $-49.0M | $721.0M | ||
| Q2 25 | $-3.0M | $718.0M | ||
| Q1 25 | $20.0M | $631.0M | ||
| Q4 24 | $-56.0M | $581.0M | ||
| Q3 24 | $471.0M | $682.0M | ||
| Q2 24 | $359.0M | $624.0M | ||
| Q1 24 | $522.0M | $599.0M |
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 71.5% | ||
| Q2 25 | — | 73.6% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 71.7% | ||
| Q1 24 | — | 70.6% |
| Q4 25 | 0.4% | 31.9% | ||
| Q3 25 | -1.0% | 37.0% | ||
| Q2 25 | 2.1% | 36.7% | ||
| Q1 25 | 3.0% | 36.5% | ||
| Q4 24 | -3.0% | 31.6% | ||
| Q3 24 | 37.3% | 36.6% | ||
| Q2 24 | 27.1% | 33.0% | ||
| Q1 24 | 31.6% | 34.1% |
| Q4 25 | -1.1% | 25.3% | ||
| Q3 25 | -2.7% | 30.0% | ||
| Q2 25 | -0.2% | 29.2% | ||
| Q1 25 | 1.2% | 28.4% | ||
| Q4 24 | -3.5% | 25.1% | ||
| Q3 24 | 28.9% | 28.6% | ||
| Q2 24 | 21.1% | 26.4% | ||
| Q1 24 | 30.5% | 27.4% |
| Q4 25 | $-0.20 | $1.37 | ||
| Q3 25 | $-0.51 | $1.63 | ||
| Q2 25 | $-0.03 | $1.61 | ||
| Q1 25 | $0.19 | $1.41 | ||
| Q4 24 | $-0.37 | $1.29 | ||
| Q3 24 | $4.63 | $1.50 | ||
| Q2 24 | $3.46 | $1.37 | ||
| Q1 24 | $4.93 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $813.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3B | $3.3B |
| Total Assets | $14.0B | $15.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $813.0M | — | ||
| Q3 25 | $749.0M | $2.1B | ||
| Q2 25 | $912.0M | $1.4B | ||
| Q1 25 | $1.8B | $1.7B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.1B | $1.7B | ||
| Q2 24 | $2.0B | $1.6B | ||
| Q1 24 | $794.0M | $2.0B |
| Q4 25 | — | — | ||
| Q3 25 | $6.0B | — | ||
| Q2 25 | $6.0B | — | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $3.8B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.9B | — | ||
| Q1 24 | $3.1B | — |
| Q4 25 | $3.3B | $3.3B | ||
| Q3 25 | $3.5B | $5.4B | ||
| Q2 25 | $3.6B | $5.0B | ||
| Q1 25 | $3.5B | $4.7B | ||
| Q4 24 | $3.5B | $4.8B | ||
| Q3 24 | $3.7B | $5.2B | ||
| Q2 24 | $3.9B | $5.0B | ||
| Q1 24 | $3.7B | $5.1B |
| Q4 25 | $14.0B | $15.5B | ||
| Q3 25 | $15.7B | $15.2B | ||
| Q2 25 | $15.9B | $14.5B | ||
| Q1 25 | $14.0B | $14.1B | ||
| Q4 24 | $13.3B | $14.2B | ||
| Q3 24 | $11.9B | $14.4B | ||
| Q2 24 | $12.8B | $14.2B | ||
| Q1 24 | $11.7B | $14.3B |
| Q4 25 | — | — | ||
| Q3 25 | 1.73× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 0.85× | — | ||
| Q2 24 | 1.01× | — | ||
| Q1 24 | 0.84× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $313.0M | $893.0M |
| Free Cash FlowOCF − Capex | $236.0M | $732.0M |
| FCF MarginFCF / Revenue | 13.2% | 30.7% |
| Capex IntensityCapex / Revenue | 4.3% | 6.7% |
| Cash ConversionOCF / Net Profit | — | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $313.0M | $893.0M | ||
| Q3 25 | $-20.0M | $938.0M | ||
| Q2 25 | $-67.0M | $486.0M | ||
| Q1 25 | $153.0M | $587.0M | ||
| Q4 24 | $235.0M | $905.0M | ||
| Q3 24 | $-21.0M | $951.0M | ||
| Q2 24 | $177.0M | $502.0M | ||
| Q1 24 | $242.0M | $595.0M |
| Q4 25 | $236.0M | $732.0M | ||
| Q3 25 | $-89.0M | $805.0M | ||
| Q2 25 | $-111.0M | $308.0M | ||
| Q1 25 | $123.0M | $438.0M | ||
| Q4 24 | $184.0M | $689.0M | ||
| Q3 24 | $-64.0M | $784.0M | ||
| Q2 24 | $135.0M | $370.0M | ||
| Q1 24 | $208.0M | $455.0M |
| Q4 25 | 13.2% | 30.7% | ||
| Q3 25 | -5.0% | 33.5% | ||
| Q2 25 | -6.1% | 12.5% | ||
| Q1 25 | 7.2% | 19.7% | ||
| Q4 24 | 11.5% | 29.7% | ||
| Q3 24 | -3.9% | 32.8% | ||
| Q2 24 | 7.9% | 15.7% | ||
| Q1 24 | 12.1% | 20.8% |
| Q4 25 | 4.3% | 6.7% | ||
| Q3 25 | 3.9% | 5.5% | ||
| Q2 25 | 2.4% | 7.2% | ||
| Q1 25 | 1.7% | 6.7% | ||
| Q4 24 | 3.2% | 9.3% | ||
| Q3 24 | 2.6% | 7.0% | ||
| Q2 24 | 2.5% | 5.6% | ||
| Q1 24 | 2.0% | 6.4% |
| Q4 25 | — | 1.48× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | 7.65× | 0.93× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | -0.04× | 1.39× | ||
| Q2 24 | 0.49× | 0.80× | ||
| Q1 24 | 0.46× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
H
| Other | $627.0M | 35% |
| Rooms Revenue | $326.0M | 18% |
| Net Fees | $290.0M | 16% |
| Distribution Segment | $177.0M | 10% |
| Franchise And Other Fees | $114.0M | 6% |
| Base Management Fees | $112.0M | 6% |
| Incentive Management Fees | $81.0M | 5% |
| Other Owned And Leased Hotel Revenue | $41.0M | 2% |
| Contra Revenue | $17.0M | 1% |
| Other Revenues | $4.0M | 0% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
